This invention relates to isoquinolino derivatives of the general Formula (I) wherein Y is >C=O or CH2-, Z is >C=O or CH2-, and R1, R2 and m are as defined in the specification, as well as their pharmaceutically acceptable salts. The invention further relates to medicaments containing these compounds, a process for their preparation as well as their use for preparation of medicaments for the treatment or prevention of diseases in which MAO-B inhibitors might be beneficial.
Isoquinoline derivatives
申请人:——
公开号:US20030225122A1
公开(公告)日:2003-12-04
Disclosed are isoquinolino derivatives of the formula
1
wherein Y is >C═O or —CH
2
—, Z is >C═O or —CH
2
—, and R
1
, R
2
and m are as defined herein as well as the pharmaceutically acceptable salts thereof. These compounds are MAO-B selective inhibitors useful, inter alia, in the treatment of Alzheimer's disease and/or senile dementia.